Skip to main content

Published locations for CLL phase 3 study: Zanubrutinib bests ibrutinib

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CLL phase 3 study: Zanubrutinib bests ibrutinib

User login

  • Reset your password
  • /content/cll-phase-3-study-zanubrutinib-bests-ibrutinib
  • /hematologynews/article/260192/cll/cll-phase-3-study-zanubrutinib-bests-ibrutinib
  • /hematology-oncology/article/260192/cll/cll-phase-3-study-zanubrutinib-bests-ibrutinib
  • /b-cell-lymphoma-icymi/article/260192/cll/cll-phase-3-study-zanubrutinib-bests-ibrutinib